These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3127359)

  • 1. Preliminary experience with ceftazidime monotherapy in perinatal infection.
    Amato M; Schaad UB
    Helv Paediatr Acta; 1987; 42(4):297-303. PubMed ID: 3127359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
    Henriksson P; Svenningsen NW; Juhlin I; Haeger K
    Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and bacteriological evaluation of cefmenoxime in the newborn infant].
    Sarlangue J; Quentin C; Megraud F; Bebear C
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):750-3. PubMed ID: 3054762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime in neonatal infections.
    Low DC; Bissenden JG; Wise R
    Arch Dis Child; 1985 Apr; 60(4):360-4. PubMed ID: 3890766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and general treatment with ceftazidime as monotherapy in central nervous system infections and in septicemic infection.
    Fiori GP; Dietz A; Montanari M; Torre D
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):326-8. PubMed ID: 3894254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.
    Rondanelli R; Dionigi RV; Regazzi MB; Maurelli M; Calvi M; Mapelli A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):457-9. PubMed ID: 3536763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
    Wong-Beringer A; Hindler J; Loeloff M; Queenan AM; Lee N; Pegues DA; Quinn JP; Bush K
    Clin Infect Dis; 2002 Jan; 34(2):135-46. PubMed ID: 11740699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
    Viganò A; Principi N
    J Chemother; 1995 Jun; 7 Suppl 2():95-101. PubMed ID: 8622117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short antibiotic prophylaxis for bacterial infections in a neonatal intensive care unit: a randomized controlled trial.
    Auriti C; Ravà L; Di Ciommo V; Ronchetti MP; Orzalesi M
    J Hosp Infect; 2005 Apr; 59(4):292-8. PubMed ID: 15749316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
    Jones ME; Karlowsky JA; Draghi DC; Thornsberry C; Sahm DF; Nathwani D
    Int J Antimicrob Agents; 2004 Mar; 23(3):240-6. PubMed ID: 15164964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime pharmacokinetics in preterm newborns on the first day of life.
    Padovani EM; Fanos V; Dal Moro A; Chiaffoni GP; Fostini R; Girelli M; Boner A
    Biol Res Pregnancy Perinatol; 1986; 7(2):71-3. PubMed ID: 3524697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal sepsis in hospital-born babies: bacterial isolates and antibiotic susceptibility patterns.
    Aurangzeb B; Hameed A
    J Coll Physicians Surg Pak; 2003 Nov; 13(11):629-32. PubMed ID: 14700488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective determination of serum ceftazidime concentrations in intensive care units.
    Aubert G; Carricajo A; Coudrot M; Guyomarc'h S; Auboyer C; Zeni F
    Ther Drug Monit; 2010 Aug; 32(4):517-9. PubMed ID: 20571462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of cefpirome in comparison with ceftazidime in Chinese patients with sepsis due to bacterial infections.
    Fang CT; Chen YC; Lin SF; Shau WY; Liu CJ; Sheng WH; Wang JT; Chang SC
    Chemotherapy; 2000; 46(5):371-8. PubMed ID: 10965103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.